In a telehealth market dominated by direct-to-consumer doctor visits, RxLive is quietly building a moat around a different specialist: the clinical pharmacist. With just 29 employees and $2.6M in revenue, they are attempting to prove that medication management, not diagnosis, is the high-value service of the future.

"RxLive isn't competing with Teladoc; they are redefining the pharmacist's role from a dispenser to a clinical provider."

The keyword data paints a picture of a company in transition. High search volume for 'rxlive is a subsidiary or scirpotlogy' (340 volume) indicates confusion in the market about their corporate structure. They appear to be closely linked to 'Scriptology,' potentially operating as a specialized vertical or subsidiary within a larger health-tech ecosystem. This lack of brand clarity is a potential friction point for organic growth.

• **Niche Focus:** Unlike generalist telehealth platforms, RxLive centers entirely on pharmacist-led care.
• **Tech Stack:** Relies on standard web tech (jQuery, Bootstrap) rather than cutting-edge frameworks, suggesting a focus on functional product over flashy UI.
• **Leadership:** Led by Chief Pharmacy Officer Kristen Engelen, signaling clinical credibility over pure tech innovation.